These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6120950)
1. Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue. Rapoport B; Takai NA; Filetti S J Clin Endocrinol Metab; 1982 May; 54(5):1059-62. PubMed ID: 6120950 [TBL] [Abstract][Full Text] [Related]
2. The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid-stimulating antibody is related to human thyrotropin. Foti D; Russo D; Costante G; Filetti S J Clin Endocrinol Metab; 1991 Oct; 73(4):710-6. PubMed ID: 1679761 [TBL] [Abstract][Full Text] [Related]
3. Studies on the cyclic AMP response to thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers. Rapoport B; Filetti S; Takai N; Seto P; Halverson G Metabolism; 1982 Nov; 31(11):1159-67. PubMed ID: 6127595 [TBL] [Abstract][Full Text] [Related]
4. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating hormone (TSH) binding to extrathyroidal human tissues: TSH binding to extrathyroidal human tissues: TSH and thyroid-stimulating immunoglobulin effects on adenosine 3',5'-monophosphate in testicular and adrenal tissues. Trokoudes KM; Sugenoya A; Hazani E; Row VV; Volpé R J Clin Endocrinol Metab; 1979 Jun; 48(6):919-23. PubMed ID: 221526 [TBL] [Abstract][Full Text] [Related]
6. Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH. Damante G; Foti D; Catalfamo R; Filetti S Metabolism; 1987 Aug; 36(8):768-73. PubMed ID: 2885711 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue. Clark OH; Gerend PL; Goretzki P; Nissenson RA J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132 [TBL] [Abstract][Full Text] [Related]
9. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates. Mehdi SQ; Badger J; Kriss JP Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685 [TBL] [Abstract][Full Text] [Related]
10. [Thyroid stimulating immunoglobulin bioassay using cultured normal human thyroid cells]. Ando M; Yamauchi K; Tanaka H; Mori Y; Takatsuki K; Yamamoto M; Matsui N; Tomita A Nihon Naibunpi Gakkai Zasshi; 1985 Aug; 61(8):847-58. PubMed ID: 2866982 [TBL] [Abstract][Full Text] [Related]
11. Both TSH and thyroid-stimulating antibody of Graves' disease bind to an Mr 197,000 holoreceptor. Islam MN; Briones-Urbina R; Bakó G; Farid NR Endocrinology; 1983 Jul; 113(1):436-8. PubMed ID: 6134614 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the human thyrotropin receptor are not species specific. Davies TF J Clin Endocrinol Metab; 1981 Mar; 52(3):426-30. PubMed ID: 6257747 [TBL] [Abstract][Full Text] [Related]
13. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759 [TBL] [Abstract][Full Text] [Related]
14. Sensitization and desensitization of human thyroid cells in culture: effects of thyrotrophin and thyroid-stimulating immunoglobulin. Kraiem Z; Alkobi R; Sadeh O J Endocrinol; 1988 Nov; 119(2):341-9. PubMed ID: 2462004 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneous signal pathways through TSH receptors in porcine thyroid cells following stimulation with Graves' immunoglobulin G. Szabó J; Fóris G; Keresztes T; Csabina S; Varga Z; Bakó G; Mezõsi E; Nagy E; Paragh G; Leövey A Eur J Endocrinol; 1998 Sep; 139(3):355-8. PubMed ID: 9758449 [TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [TBL] [Abstract][Full Text] [Related]
17. Evidence for persistent binding of biologically active thyrotropin to thyroid in vitro. DeRubertis FR; Chayoth R; Zor U; Field JB Endocrinology; 1975 Jun; 96(6):1579-86. PubMed ID: 165069 [TBL] [Abstract][Full Text] [Related]
18. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse. Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983 [TBL] [Abstract][Full Text] [Related]
19. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease. Loeffler M; Zakarija M; McKenzie JM J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706 [TBL] [Abstract][Full Text] [Related]
20. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins. Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]